🇺🇸 SUPERNUS PHARMACEUTICALS, INC.SUPN
Get SUPERNUS PHARMACEUTICALS, INC. filings on Telegram the moment they are published.
Follow SUPERNUS PHARMACEUTICALS, INC. on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 8-K Items 1.01, 2.01, 2.03, 3.03, 5.01, 5.03, 7.01, 9.01
Overview: Completed merger between Supernus Pharmaceuticals, Inc. and Indivior Pharmaceuticals, Inc. on November 2, 2026, involving a $1.0 billion special cash dividend to Indivior stockholders.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest